EASL 2025 indications revisited: phase-specific outcomes with and without nucleos(t)ide analogue therapy in chronic hepatitis B virus infection

Journal:
Gut
Published:
Affiliations:
37
Authors:
31
Institutions Authors Share
Fujian Medical University, China
7.833333
0.25
Mengchao Hepatobiliary Hospital of Fujian Medical University, China
5.083333
0.16
State Key Laboratory of Molecular Oncology, China
2.000000
0.06
Eastern Hepatobiliary Surgery Hospital (EHBH), SMMU, China
2.000000
0.06
Zizhong County People's Hospital, China
1.000000
0.03
Wenjiang District People's Hospital, China
1.000000
0.03
West China School of Public Health /West China Fourth Hospital, SCU, China
1.000000
0.03
Zhongshan Hospital of Xiamen University, China
1.000000
0.03
Xiamen Hospital of Traditional Chinese Medicine, China
1.000000
0.03
Guizhou Maotai Hospital, China
1.000000
0.03
Ningde Hospital affiliated to Ningde Normal University, China
1.000000
0.03
Longyan First Hospital, China
1.000000
0.03
Beijing Youan Hospital, China
1.000000
0.03
Zhongda Hospital, SEU, China
1.000000
0.03
Liver Center of Fujian Province at Mengchao Hepatobiliary Hospital, China
0.750000
0.02
The First Affiliated Hospital of Fujian Medical University, China
0.500000
0.02
Heze Municipal Hospital, China
0.500000
0.02
Shandong First Medical University and Shandong Academy of Medical Sciences (SFMU), China
0.500000
0.02
Mindong Hospital of Ningde City, China
0.500000
0.02
Fuqing Affiliated Hospital of Fujian Medical University, China
0.500000
0.02
Zhangzhou Municipal Hospital of Fujian Province, China
0.500000
0.02
Wanyuan People's Hospital, China
0.333333
0.01